We also measured GPNMB for 16 patients with benign breast disease, including patients with fibroadenoma and mastopathy, and cancer-free patients, whose GPNMB level was 8.029 ng/mL which was not statistically different from that of BC, CC, and GC patients. This evidence concerns the gene GPNMB and breast cancer.